Stock BPTH BIO-PATH HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Bio-Path Holdings, Inc.

Equities

BPTH

US09057N4097

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
2.81 USD +1.81% Intraday chart for Bio-Path Holdings, Inc. +5.64% -69.65%
04-19 Bio-Path Closes $1.2 Million Share Offering MT
04-18 Bio-Path Holdings, Inc. Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1B Clinical Trial of Bp1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bio-Path Holdings, Inc. Appoints Aline Sherwood to its Board of Directors
CI
Bio-Path Holdings, Inc. Announces Resignation of Martina Molsbergen as Member of the Board and All Committees of the Board
CI
Bio-Path Holdings, Inc. Announces Board Changes
CI
Bio-Path Holdings, Inc. Appoints Paul D. Aubert as Director
CI
Bio-Path Holdings, Inc. Appoints Dr. Jason B. Fleming to its Scientific Advisory Board
CI
Bio-Path Holdings, Inc. Appoints Anas Younes to Scientific Advisory Board
CI
Bio-Path Holdings, Inc. Appoints Paul Aubert to Its Board of Directors
CI
Bio-Path Holdings, Inc. Announces Resignation of Ulrich W. Mueller as Chief Operating Officer
CI
Bio-Path Holdings, Inc. Announces Resignation of Directors
CI
Bio-Path Holdings, Inc. Appoints Mark Colonnese to its Board of Directors
CI
Bio-Path Holdings Announces the Appointment of William Hahne as Vice President of Clinical Development
CI
Bio-Path Holdings Appoints Dr. Craig Hooper to Scientific Advisory Board
CI
Bio-Path Holdings, Inc. Announces Board Appointments
CI
Bio-Path Holdings, Inc. Appoints Tara Sadeghi as Director of Clinical Operations
CI
Bio-Path Holdings, Inc. Announces Board Changes
CI
Bio-Path Holdings, Inc. Announces Resignation of Douglas P. Morris as Vice President of Corporate Development and Secretary, Effective June 30, 2014
CI
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller as Chief Operating Officer
CI
Bio-Path Holdings, Inc. Announces Management Appointments
CI
Bio-Path Holdings, Inc. Elects Michael J. Garrison as Director
CI
Bio-Path Holdings, Inc. Appoints Michael J. Garrison as Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BPTH Stock
  4. News Bio-Path Holdings, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW